How do you manage classical early stage Hodgkin lymphoma patients when an ESR is not checked as part of their workup?

For example, would you go ahead with 20 Gy of ISRT if medical oncology has already treated a stage I-IIA patient with 2 cycles of ABVD meeting all other favorable criteria by the GHSG criteria except the ESR was not checked prior to treatment? Or would you recommend a different approach?

1 Answer

Mednet Member

Radiation Oncology · Washington University School of Medicine

Answered on

I personally don't think ESR plays a huge factor in the management of early stage Hodgkin Lymphoma now in the era of PET-adapted treatment selection. So, if a patient has very favorable stage I-IIA HL meeting all other criteria by the GHSH study and is interested to not have combined modality treatm...

Join for free or sign in to see the full answer